Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Heads Should Roll

<< Previous

Bullboard Posts

Next >>

Comment by FGPstockon Apr 05, 2022 10:29pm

187 Views

Post# 34579015

RE:Heads Should Roll

#FINANANCING. look at 2019, TLT did the same thing. not the way to raise money. Results were great, management still can't seem to put things together... I expect it to play out the same way they did last time. There is no way we should have the same valuation as 2019, but here we are...

<< Previous

Bullboard Posts

Next >>

POET increases production capacity to meet AI demand